Cargando…
A Seven-NF-κB-Related Gene Signature May Distinguish Patients with Ulcerative Colitis-Associated Colorectal Carcinoma
PURPOSE: Ulcerative colitis (UC) patients have an increased risk of colorectal cancer (CRC), and compared with sporadic CRC, ulcerative colitis-associated colorectal cancer (CAC) is more aggressive with a worse prognosis. This study aimed to identify a gene signature to predict the risk of CAC for p...
Autores principales: | Ge, Chao-Yi, Wei, Li-Yuan, Tian, Yu, Wang, Hua-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719442/ https://www.ncbi.nlm.nih.gov/pubmed/33299340 http://dx.doi.org/10.2147/PGPM.S274258 |
Ejemplares similares
-
The Protection of Crocin Against Ulcerative Colitis and Colorectal Cancer via Suppression of NF-κB-Mediated Inflammation
por: Teng, Shanshan, et al.
Publicado: (2021) -
Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines
por: Lu, Peng-De, et al.
Publicado: (2020) -
Shikimic Acid Regulates
the NF-κB/MAPK Signaling
Pathway and Gut Microbiota to Ameliorate DSS-Induced Ulcerative Colitis
por: Li, Xin, et al.
Publicado: (2023) -
Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
por: Zhang, Xu, et al.
Publicado: (2020) -
Molecular characterization of ulcerative colitis-associated colorectal carcinomas
por: Hirsch, Daniela, et al.
Publicado: (2020)